Valneva SE
OTC:INRLF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Valneva SE
OTC:INRLF
|
FR |
|
Diamondback Energy Inc
NASDAQ:FANG
|
US |
|
Mallcom (India) Ltd
NSE:MALLCOM
|
IN |
|
G
|
Goodman Group
F:MY4
|
AU |
|
C
|
Churchill Resources Inc (ON)
XTSX:CRI
|
CA |
|
L
|
L3Harris Technologies Inc
F:HRS
|
US |
|
Hensel Davest Indonesia Tbk PT
IDX:HDIT
|
ID |
|
D
|
Daechang Solution Co Ltd
KOSDAQ:096350
|
KR |
|
China Gold International Resources Corp Ltd
TSX:CGG
|
CA |
|
Japan Exchange Group Inc
TSE:8697
|
JP |
Intrinsic Value
Is INRLF undervalued or overvalued?
See the intrinsic value estimate for
Valneva SE and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Valneva Does
Valneva is a vaccine company. It develops, makes, and sells vaccines that help prevent infectious diseases, with a focus on travel and other niche areas where public health agencies and doctors need specific protection rather than broad everyday medicines. Its best-known products include vaccines for diseases such as Japanese encephalitis, cholera, and other travel-related infections, along with vaccine candidates still in development.
- Headquarters
- France FR
- Employees
- 674
- IPO date
- Jun 28, 2007
Revenue & Expenses Breakdown
Valneva SE
Earnings Waterfall
Valneva SE
The intrinsic value for
Valneva SE (INRLF) under the Base Case is hidden USD.
Compared with the current market price of 2.49 USD, the stock appears hidden.